Studies references | In-hospital Mortality | DVT In hosp | RBC (unit) | Platelets (unit) | FFP (unit) | Other outcomes reported |
---|---|---|---|---|---|---|
Jehan [26] | PCC + FFP: 10 (25) FFP 26 (33) p = 0.04* | PCC + FFP: 1 (2.5) FFP: 1 (1.2) p = 0.51* | Unclear PCC + FFP: 7 (3)µ FFP: 9 (5)µ p < 0.04* | Unclear PCC + FFP: 3 (3)µ FFP: 3 (3)µ p = 0.72* | Unclear PCC + FFP: 5 (2)µ FFP: 7 (3)µ p = 0.03* | Proportion of patients with INR correction and time to INR correction from admission* Rate of correction of INR* Other TE*: PE, Mesenteric ischemia ICU and Hospital LOS |
Joseph [31] | PCC + FFP: 15 (23) FFP alone: 53 (28) p = 0.04 | PCC + FFP: 1 (1.6) FFP alone: 2 (1.1) p = 0.6* | Total PCC + FFP: 6.6 (4.1)µ FFP alone: 10 (8.3)µ p = 0.001* | Total PCC + FFP: 1.2 (2.1)µ FFP alone: 1.5 (2.7)µ p = 0.2* | Total PCC + FFP: 2.8 (1.8)µ FFP alone: 3.9 (1.3)µ p = 0.01* | Proportion of patients with INR correction and time to INR correction from admission* Time to treatment* Mesenteric infarction* ICU and Hospital LOS Costs: therapy*, transfusion*, hospital |
Joseph [24] | PCC: 6 (22.3) FFP 15 (27.8) p = 0.78 | PCC: 3 (11.1) FFP: 4 (7.4) p = 0.68* | Total PCC: 3.2 (1.9)µ FFP: 5.4 (4.1)µ p = 0.009* | Total PCC: 1.4 (2.3)µ FFP: 1.6 (2.4)µ p = 0.72* | Total PCC: 5.1 (3.6)µ FFP: 90.7 (4.1)µ p = 0.005* | Proportion of patients with INR correction and time to INR correction from admission* Time to treatment Time to surgery Mesenteric or myocardial infarction ICU and Hospital LOS Costs: therapy, transfusion, hospital, charges |
Khurrum [27] | PCC + WB: 39 (46) WB 74 (44) p = 0.72* | PCC + WB: 3 (4) WB: 8 (5) p = 0.75 | At 24 h PCC + WB: 8 (5–14)$ WB: 10 (6–18)$ p = 0.04* | At 24 h PCC + WB: 2 (1–3)$ WB: 2 (1–4)$ p = 0.19* | At 24 h PCC + WB: 6 (4–10)$ WB: 8 (4–12)$ p = 0.01* | PCC units In ED mortality ED, ICU and hospital LOS AKI, ARDS, PE |
Ponschab [30] | – | – | At 24 h All patients: 7 (3–10) [7] | At 24 h All patients: 0 (0–00) [7] | At 24 h All patients: 0 (0–0)7 | ROTEM parameter PCC unit, FC (g) and TXA (g) administrated at 24 h |
Schlimp [28] | PCC + FC: 18 (29) FC: 7 (8) PCC + FC + FFP: 5 (56) p < 0.0001 | – | At 24 h PCC + FC: 8 (5–11)$ FC: 3 (2–6)$ PCC + FC + FFP: 21 (18–26)$ p < 0.0001 | At 24 h PCC + FC: 0 (0–0)$ FC: 0 (0–0)$ PCC + FC + FFP: 4 (2–4)$ p < 0.001 | At 24 h PCC + FC: none FC: none PCC + FC + FFP: 6 (6–10)$ p = NA | Transfusion (RBC, FFP, platelet, FC, PCC) volume in ED and ICU Massive transfusion Standard and specific coagulation tests including ROTEM over 7 days |
Schöchl [29] | PCC + FC: 0 (0) FC: 0 (0) NCT: 0 (0) | - | At 24 h PCC + FC: 8 (6–10.5)$ FC: 3 (0–5)$ NCT: 0 (0–2)$ p < 0.001 | At 24 h PCC + FC: 0 (0–1)$ FC: 0 (0–0)$ NCT: 0 (0–0)$ p < 0.001 | At 24 h PCC + FC: 0 (0–0)$ FC: 0 (0–0)$ NCT: 0 (0–0)$ p = ns | PCC and FC unit transfused Standard and specific coagulation tests including ROTEM over 7 days |
Zeeshan [25] | 4F-PCC: 32 (26) 3F-PCC: 35 (28) p = 0.78* | 4F-PCC: 2 (1.4) 3F-PCC: 3 (2.1) p = 0.81* | Total 4F-PCC: 7 (2)µ 3F-PCC: 10 (3)µ p = 0.04* | Total 4F-PCC: 3 (3)µ 3F-PCC: 3 (3)µ p = 0.23* | Total 4F-PCC: 6 (2)µ 3F-PCC: 8 (2)µ p = 0.03* | Proportion of patients with INR correction and time to INR correction from admission* ICU and Hospital LOS Other TE*: Mesenteric infarction, PE Costs: therapy, transfusion, total hospital |
Zeeshan 2018 [26] | 4-PCC + FFP: 41 (17.5) FFP: 65 (27.7) p = 0.01* | PCC + FFP: 8 (3.4) FFP: 13 (5.5) p = 0.11 | At 24 h PCC + FFP: 6 (4)µ FFP: 10 (4)µ p = 0.02* | At 24 h PCC + FFP: 3 (2)µ FFP: 3 (3)µ p = 0.72* | At 24 h PCC + FFP: 3 (2)µ FFP: 6 (3)µ p = 0.01* | ED mortality* Transfusion at 4 h* ICU and Hospital LOS Skilled nursing facility or rehab. disposition Complications: AKI, ARDS, PE |